Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

    Journal of Clinical Medicine, Vol. 8, Núm. 8